Why Bio Protocol’s recovery hinges on the $0.18 price level

ambcryptoPublicado a 2025-09-06Actualizado a 2025-09-07

Key Takeaways

Bio Protocol saw a healthy momentum reset on the 1-day timeframe, and a 62% jump in Open Interest in the past 24 hours was one of the factors that signaled imminent bullish strength.


Bio Protocol [BIO] has begun to recover from its deep retracement. The $286 million market cap token retraced deeper than anticipated in a recent AMBCrypto report, where $0.15 was highlighted as an important support.

BIO fell to the base of the rally that began on the 19th of August. In doing so, its market structure on the daily timeframe reverted bearishly. Bitcoin [BTC] decoupled from the stock market, fueling hopes of an altseason.

Ethereum [ETH] saw its validator queue climb to 860k ETH. The Ethereum smart contract EigenLayer saw its Total Value Locked (TVL) reach a record $21 billion, implying ETH is staked at a record pace.

The market leaders, Bitcoin and Ethereum, could help shift the crypto sentiment bullishly, which would positively impact BIO.

Until then, Bio Protocol bulls need to bide their time and claw back some of the gains they lost during the retracement.

The path ahead for Bio Protocol

BIO 1-day ChartBIO 1-day Chart

Source: BIO/USDT on TradingView

The RSI on the 1-day timeframe has reset toward neutral 50 after climbing to 84 two weeks ago. This reflected a healthy reset for the momentum and BIO bulls.

The swing structure was bullish as the price was still above the higher low at $0.1209. However, the internal structure was bearish, but a move beyond $0.18 could change this.

Compared to early August, the OBV was also floating higher, like the price, reflecting that buying pressure has been dominant despite the recent price setback. Continued buying and OBV uptick would signal Bio Protocol strength.

BIO 4-hour ChartBIO 4-hour Chart

Source: BIO/USDT on TradingView

The 4-hour chart indicated that traders should expect bullish strength in the coming days. The OBV leapt higher after the recent setback. So did BIO prices, clearing the bearish order block (cyan) at $0.162-$0.173.

At the time of writing, this zone was being retested as support. The 4-hour price structure was bullish, and more gains appeared likely over the weekend and the next week.

Disclaimer: The information presented does not constitute financial, investment, trading, or other types of advice and is solely the writer’s opinion

Share

Criptos en tendencia

Lecturas Relacionadas

Sevenfold Oversubscription, Can SK Hynix Save the Semiconductor Industry This Time?

SK Hynix's planned US ADR listing is drawing intense interest, with its offering reportedly oversubscribed by over seven times, potentially making it the largest foreign listing in US history. The fundraising of approximately $24.5 billion is intended for expanding its Korean production capacity, including advanced packaging and EUV equipment. This massive demand from long-term funds and prominent institutions like Baillie Gifford and Situational Awareness Partners (led by noted investor Leopold Aschenbrenner) presents a stark contrast to the recent downturn in the broader semiconductor sector. The sector has faced a significant correction, with SK Hynix's own stock falling nearly 30% from its June high. This sell-off was triggered by concerns that major tech giants might slow their AI infrastructure spending, following signals like Meta's reported plan to sell surplus computing capacity. The strong ADR appetite suggests long-term investors still believe in the AI investment cycle's fundamentals, viewing the recent decline more as a valuation reset than a demand collapse. Some market speculation even suggests the pre-IPO price drop could be strategic, setting the stage for a stronger post-listing performance. While SK Hynix's successful listing may act as a short-term positive catalyst for market sentiment, the article argues the true signal for a sustained semiconductor recovery will come from upcoming earnings reports of tech giants like Microsoft, Google, Meta, and Amazon. Their future capital expenditure plans will be crucial in determining whether the AI-driven growth cycle can continue.

Odaily星球日报Hace 19 min(s)

Sevenfold Oversubscription, Can SK Hynix Save the Semiconductor Industry This Time?

Odaily星球日报Hace 19 min(s)

Breaking News: Musk Delivers the Most Powerful Grok 4.5, Slashes Price of Top-tier Opus Intelligence Drastically

**Elon Musk Launches Grok 4.5: A Cost-Effective, High-Performance AI Rival** SpaceXAI, in collaboration with Cursor, has released Grok 4.5, its new flagship AI model designed specifically for coding and agentic tasks. Trained on tens of thousands of NVIDIA GB300 GPUs using massive, high-quality data filtered from trillions of Cursor developer interactions, the model emphasizes "per-token intelligence." In benchmark performance, Grok 4.5 is highly competitive. It scores 64.7% on SWE Bench Pro (surpassing GPT-5.5's 58.6% and Opus 4.7's 64.3%), 83.3% on Terminal Bench 2.1 (nearly matching GPT-5.5), and 62.0% on DeepSWE 1.0 (beating Opus 4.8). Overall, it ranks fourth in AAAI official tests and first in the Harvey legal agent benchmark. The model's key advantage is its combination of speed, efficiency, and low cost. It generates responses at 80 tokens per second and, crucially, uses far fewer tokens to complete tasks—4.2 times fewer than Opus 4.8 on SWE Bench Pro. It is priced at $2 per million input tokens and $6 per million output tokens, significantly undercutting competitors. Musk stated it is "roughly equivalent to Opus 4.7, but much faster." Early user tests show Grok 4.5 can generate functional code for applications like 3D solar system simulators and basic games from simple prompts, though some note it still lags behind top models in certain creative tasks. Musk has hinted at a major update next month, leveraging real-world engineering data from his companies, with an even larger 2-trillion parameter version reportedly in development. Grok 4.5 positions itself not as the absolute strongest model, but as a highly efficient and affordable alternative in the top tier.

marsbitHace 24 min(s)

Breaking News: Musk Delivers the Most Powerful Grok 4.5, Slashes Price of Top-tier Opus Intelligence Drastically

marsbitHace 24 min(s)

Today, The Hong Kong Exchange Was Once Again Overwhelmed

Hong Kong's stock exchange witnessed an exceptionally busy day on July 9, with a record seven companies conducting initial public offerings (IPOs) simultaneously. The list included major firms such as Luxshare Precision, which launched the largest Hong Kong IPO of the year, and other notable names like Tri-Ring Group and Qiyunshan Food. However, the market reception was sharply divided on the first trading day. While Qiyunshan Food's shares surged over 110%, several other newcomers, including Luxshare Precision, Dingtai High-Tech, and Rigol Technologies, opened below their issue prices, with some falling nearly 20%. This event highlights a broader, bustling IPO scene in Hong Kong for 2024, with 82 Chinese companies listing in the first half alone—more than double the figure from the same period last year. A significant portion of this activity comes from dual "A+H" listings, where mainland China-listed firms seek secondary listings in Hong Kong. These larger companies have accounted for nearly 60% of total fundraising. Despite the high volume, recent trends show a cooling market sentiment for many new listings. Several IPOs in early July, including that of Tongrentang Healthcare, debuted with significant losses, indicating increased investor caution and selectivity. The market narrative is shifting, with capital increasingly concentrating on high-growth sectors like artificial intelligence, robotics, and semiconductors, while traditional manufacturing and consumer goods face greater pressure and volatility. This divergence underscores a market where success is no longer guaranteed by merely listing, but depends heavily on a company's growth prospects and sector appeal.

marsbitHace 28 min(s)

Today, The Hong Kong Exchange Was Once Again Overwhelmed

marsbitHace 28 min(s)

Glassnode: Crypto Market Enters Later Stages of Bottoming Phase

Glassnode: Crypto Market Enters Later Stages of Bottom Formation Bitcoin has traded below the true market average and the short-term holder cost basis for five consecutive months, indicating a deep undervaluation. On-chain data reveals a significant shift in selling pressure, with long-term holders now accounting for 43% of all realized losses. Daily realized losses for this group recently peaked at $280 million, the highest level since December 2022. While this large-scale capitulation is a hallmark of bear market bottoms, a sustained decline in this metric is a prerequisite for a sustained recovery. Institutional demand remains weak. US spot Bitcoin ETFs continue to see monthly net outflows, although the pace has moderated from June's peak. Furthermore, average daily ETF trading volumes have contracted by approximately 80% from their October 2025 peak, reflecting subdued institutional participation. Derivatives markets present a mixed picture. Overall positioning has shifted to cautiously bullish, with the put/call ratio dropping to a yearly low. However, the options volatility skew remains elevated, signaling that traders are still paying a premium for downside protection. The spot price also trades below the gamma "max pain" level. In summary, multiple indicators suggest the market is in the later phases of a bottoming process, characterized by long-term holder capitulation and weak institutional inflows. However, key confirmation signals for a durable trend reversal—a sustained drop in long-term holder selling pressure, stabilization of ETF flows, and a price recovery above key cost bases—are still pending.

Foresight NewsHace 55 min(s)

Glassnode: Crypto Market Enters Later Stages of Bottoming Phase

Foresight NewsHace 55 min(s)

Trading

Spot

Artículos destacados

Cómo comprar BIO

¡Bienvenido a HTX.com! Hemos hecho que comprar BIO Protocol (BIO) sea simple y conveniente. Sigue nuestra guía paso a paso para iniciar tu viaje de criptos.Paso 1: crea tu cuenta HTXUtiliza tu correo electrónico o número de teléfono para registrarte y obtener una cuenta gratuita en HTX. Experimenta un proceso de registro sin complicaciones y desbloquea todas las funciones.Obtener mi cuentaPaso 2: ve a Comprar cripto y elige tu método de pagoTarjeta de crédito/débito: usa tu Visa o Mastercard para comprar BIO Protocol (BIO) al instante.Saldo: utiliza fondos del saldo de tu cuenta HTX para tradear sin problemas.Terceros: hemos agregado métodos de pago populares como Google Pay y Apple Pay para mejorar la comodidad.P2P: tradear directamente con otros usuarios en HTX.Over-the-Counter (OTC): ofrecemos servicios personalizados y tipos de cambio competitivos para los traders.Paso 3: guarda tu BIO Protocol (BIO)Después de comprar tu BIO Protocol (BIO), guárdalo en tu cuenta HTX. Alternativamente, puedes enviarlo a otro lugar mediante transferencia blockchain o utilizarlo para tradear otras criptomonedas.Paso 4: tradear BIO Protocol (BIO)Tradear fácilmente con BIO Protocol (BIO) en HTX's mercado spot. Simplemente accede a tu cuenta, selecciona tu par de trading, ejecuta tus trades y monitorea en tiempo real. Ofrecemos una experiencia fácil de usar tanto para principiantes como para traders experimentados.

328 Vistas totalesPublicado en 2025.01.02Actualizado en 2026.06.02

Cómo comprar BIO

Discusiones

Bienvenido a la comunidad de HTX. Aquí puedes mantenerte informado sobre los últimos desarrollos de la plataforma y acceder a análisis profesionales del mercado. A continuación se presentan las opiniones de los usuarios sobre el precio de BIO (BIO).

活动图片